What Researchers Did
This review synthesized current knowledge on how probiotics can modulate the immune system to combat chronic and acute diabetic foot ulcers (DFUs).
What They Found
The review highlighted that diabetic foot ulcers are characterized by poor angiogenesis and neuropathy, leading to opportunistic pathogen biofilms and delayed healing. It identified four conventional therapies, debridement, hyperbaric oxygen, shock wave, and antibiotics, whose effectiveness is limited by pathogen evolution, and proposed probiotics as a novel approach to regulate gut-skin interaction and immune responses. The review also explored innovative probiotic delivery methods, including encapsulation and nanoformulations with prebiotics and extracellular vesicles.
What This Means for Canadian Patients
Canadian patients suffering from diabetic foot ulcers might benefit from future probiotic-based therapies that could offer a novel way to manage infections and promote wound healing. These approaches could potentially complement existing treatments, providing new options for a condition that often leads to severe complications.
Canadian Relevance
This review did not include any specific Canadian data or research, nor did it involve Canadian authors or institutions.
Study Limitations
As a review, this study did not present new experimental data or clinical trial results, but rather synthesized existing literature.